Pages that link to "Q36986054"
Jump to navigation
Jump to search
The following pages link to The use of i.v. IG therapy in dermatology (Q36986054):
Displaying 13 items.
- Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. (Q30318994) (← links)
- Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. (Q34548422) (← links)
- Treatment of Cutaneous Lupus (Q35633324) (← links)
- Long-term efficacy of biologics in dermatology (Q37394846) (← links)
- High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases (Q37532013) (← links)
- Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis. (Q37802203) (← links)
- Intravenous immunoglobulin in dermatology (Q42010655) (← links)
- Toxic epidermal necrolysis associated with deflazacort therapy with nephrotic syndrome (Q43086784) (← links)
- Appropriate off-label prescription in practice (Q43969745) (← links)
- Unraveling the IVIG mystique (Q48304490) (← links)
- S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). (Q52836583) (← links)
- Linear IgA bullous dermatosis following autologous PBSC transplantation in a patient with non-Hodgkin's lymphoma (Q84039451) (← links)
- Adjuvant Low Dose Intravenous Immunoglobulin Treatment for Severe, Refractory Atopic Dermatitis – Pediatric Case Series (Q91666147) (← links)